Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study
- Status
- UNKNOWN
- Phase
- NA
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
- Status
- COMPLETED
- Phase
- NA
Patient-reported Outcomes in Bladder Cancer
- Status
- COMPLETED
- Phase
- NA
Genomic Imprinting Testing for Diagnosis of Bladder Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
- Status
- WITHDRAWN
- Phase
- PHASE2
Circulating Tumor DNA Exposure in Peripheral Blood
- Status
- UNKNOWN
- Phase
- N/A
The Effect of Goal-directed Hemodynamic Therapy in Radical Cystectomy
- Status
- COMPLETED
- Phase
- NA